ArticleOpen forum infectious diseases2015

Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.

Edgar Turner Overton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.